Grass pollen sublingual immunotherapy (high-dose)

grass pollen extract for sublingual immunotherapy · Allergopharma GmbH & Co. KG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Grass pollen sublingual immunotherapy (high-dose), covering 2013-11-08 to 2013-11-08. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety From a High-dosed Sublingual Grass Pollen Preparation [Phase 3]